Malaria, a life-threatening blood disease, has been a major concern in the field of healthcare. One of the severe forms of malaria is caused by the parasite Plasmodium falciparum which is initiated through protein interactions of pathogen with the host proteins. It is essential to analyse the protein-protein interactions among the host and pathogen for better understanding of the process and characterizing specific molecular mechanisms involved in pathogen persistence and survival. In this study, a complete protein-protein interaction network of human host and Plasmodium falciparum has been generated by integration of the experimental data and computationally predicting interactions using the interolog method. The interacting proteins were filtered according to their biological significance and functional roles. α-tubulin was identified as a potential protein target and inhibitors were designed against it by modification of amiprophos methyl. Docking and binding affinity analysis showed two modified inhibitors exhibiting better docking scores of -10.5 kcal/mol and -10.43 kcal/mol and an improved binding affinity of -83.80 kJ/mol and -98.16 kJ/mol with the target. These inhibitors can further be tested and validated in vivo for their properties as an antimalarial drug.
Keyphrases
- plasmodium falciparum
- protein protein
- small molecule
- healthcare
- candida albicans
- binding protein
- molecular dynamics simulations
- amino acid
- electronic health record
- mass spectrometry
- magnetic resonance imaging
- molecular docking
- drug induced
- health information
- climate change
- computed tomography
- human health
- data analysis